Ozempic vs. Wegovy: Same Drug, Very Different Purpose

Ozempic and Wegovy contain semaglutide, but their approved uses, doses and instructions differ. For weight management, ask about the product approved for that purpose and your individual eligibility.

Here’s the clear breakdown of what’s actually going on, and what your real options are if you can’t get either one affordably.

---

Recommendations and results for approved medicines depend on the indication and product. NIDDK describes weight-management medication as part of a plan that also includes nutrition, activity and follow-up. Source: NIDDK: prescription weight-management medicines

Are Ozempic and Wegovy the Same Drug?

Yes — both contain the same active ingredient: semaglutide, a GLP-1 receptor agonist made by Novo Nordisk.

The difference is what the FDA approved each one for:

• Ozempic — FDA-approved in 2017 for type 2 diabetes
• Wegovy — FDA-approved in 2021 for chronic weight management

That’s it. Same molecule. Different label. Different marketing. Different insurance pathways.

This is more common in pharma than people realize. The same compound can be packaged and approved for different conditions, often at different doses, and given different brand names. Bupropion is sold as Wellbutrin (depression) and Zyban (smoking cessation). Sildenafil is sold as Viagra (erectile dysfunction) and Revatio (pulmonary hypertension). Same drug, different official use case.

---

Key Differences: Dose, Approval, Insurance Coverage

Here’s where the real-world differences show up:

Dosing

• Ozempic maxes out at 2.0mg weekly (it has a 2.4mg “compounded” dose used in some studies, but the prescribing label tops at 2.0mg)
• Wegovy is approved up to 2.4mg weekly — the dose used in the STEP weight-loss trials

For weight loss, the higher 2.4mg dose tends to produce better results — which is why Wegovy is the “official” weight-loss version.

FDA Indication

• Ozempic = type 2 diabetes (and recently, cardiovascular risk reduction in patients with diabetes)
• Wegovy = obesity (BMI ≥30, or BMI ≥27 with weight-related condition); approved 2024 to reduce cardiovascular events in adults with obesity and existing heart disease

Insurance Coverage

This is where most patients get stuck:

• Ozempic is often covered for diabetes — but insurers reject “off-label” use for weight loss
• Wegovy is sometimes covered for weight loss, but most commercial plans require step therapy, prior authorization, or simply exclude weight-loss medications entirely
• Medicare has historically excluded weight-loss medications, though recent changes are slowly opening some coverage

Brand prices vary by formulation, dose, coverage and offer eligibility. Confirm the supply length and ongoing price in current manufacturer terms before comparing with a compounded preparation. Source: Ozempic manufacturer savings terms Source: Zepbound manufacturer savings terms

Pricing

Brand prices vary by formulation, dose, coverage and offer eligibility. Confirm the supply length and ongoing price in current manufacturer terms before comparing with a compounded preparation. Source: Ozempic manufacturer savings terms Source: Zepbound manufacturer savings terms

---

Ozempic for Weight Loss: Off-Label Use Explained

Because Ozempic and Wegovy are the same drug, many licensed providers prescribe Ozempic off-label for weight loss when patients can’t get Wegovy covered. This is legal and common — licensed providers are allowed to prescribe approved medications for non-approved uses based on their clinical judgment.

The catch:

• Insurance is even less likely to cover Ozempic for weight loss than for diabetes
• Some insurers actively flag “off-label” prescriptions and reject them
• The maximum Ozempic dose (2.0mg) is slightly below the optimal weight-loss dose (2.4mg) used in the STEP trials

For patients without diabetes who specifically want semaglutide for weight management, Wegovy is technically the right product — but practical access is brutal.

---

Why Most Patients Can’t Get Ozempic or Wegovy Affordably

The brutal truth in 2026 is that most American adults who could benefit from semaglutide can’t afford the brand-name version.

Why:

Brand prices vary by formulation, dose, coverage and offer eligibility. Confirm the supply length and ongoing price in current manufacturer terms before comparing with a compounded preparation. Source: Ozempic manufacturer savings terms Source: Zepbound manufacturer savings terms

The result: millions of patients who medically qualify simply can’t access the medication.

---

Compounded Semaglutide: The Accessible Alternative

This is where compounded semaglutide comes in.

Compounded semaglutide is prepared by state-licensed 503A compounding pharmacies. These facilities operate under current Good Manufacturing Practice (cGMP) standards — the same general framework that applies to drug manufacturers.

What that means:

• ✅ Semaglutide, the active medication (base or salt form), in a compounded preparation that is not FDA-approved and not a generic of Ozempic® or Wegovy®
• ✅ Federal oversight of the pharmacy facility
• ✅ Batch testing for sterility, potency, and contamination
• ✅ Prescribed by a licensed US provider after a real medical review Source: FDA: risks of compounded medicines

What it doesn’t mean:

• ❌ Not FDA-approved as a final product (it is prepared by a state-licensed US 503A compounding pharmacy)
• ❌ Not an exact bioequivalent in the formal regulatory sense

For patients who can’t access affordable brand-name semaglutide, compounded preparations are offered by some telehealth providers under individual prescriptions from licensed providers. Compounded semaglutide is a non-FDA-approved preparation, is not a generic version of, and is not the same as, Ozempic® or Wegovy®, and has not been clinically studied as a finished product.

---

REMEVi vs. Brand-Name Ozempic/Wegovy: Cost Comparison

Here’s the real-world math over a 12-month treatment period:

Brand prices vary by formulation, dose, coverage and offer eligibility. Confirm the supply length and ongoing price in current manufacturer terms before comparing with a compounded preparation. Source: Ozempic manufacturer savings terms Source: Zepbound manufacturer savings terms

REMEVi includes everything in that one price: clinical evaluation, medication, syringes, shipping, and bilingual care support. There’s no separate consult fee, no shipping fee, no surprise renewal charge.

For patients without strong weight-loss insurance coverage, compounded semaglutide through a legitimate platform is dramatically more accessible than the brand-name versions.

---

Ready to Get Started?

If you’ve been priced out of Ozempic or Wegovy, you have a real, legitimate alternative. REMEVi compounded semaglutide is sourced from a state-licensed US compounding pharmacy, prescribed by licensed US providers, and is one flat price — the same at every dose — published on our semaglutide page — all-inclusive.

The intake form takes 2 minutes. A licensed US clinical reviews your file within 24 hours. Medication ships within 3–4 days.

Start your free consultation →

Want a deeper look at the compounded option? Read What Is Compounded Semaglutide? For all pricing tiers and plan options, see our pricing page.

---

This article is for informational purposes only and does not constitute medical advice. Consult with a licensed provider — including through REMEVi’s telehealth platform — before starting any prescription medication.

Current formulation note

Weekly schedules in this article refer to injections. Wegovy also has approved tablets, and Ozempic has separate tablet information. A compounded oral preparation does not share those approvals. Confirm the formulation and its label; do not convert doses between routes yourself. Novo Nordisk: Ozempic formulations Ozempic injection: prescribing information Wegovy: prescribing information